SRZN News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$276.1M

Volume

232.39K

Next Earnings

November 6th

Mkt Cap

$275.5M

Volume

232.39K

Next Earnings

November 6th

Chart Financials Earnings News About Insider Filings

Surrozen Reports Q2 Profit on GainsBiotechnology company Surrozen reported a surprising Q2 2025 net income of $39.7 million, driven primarily by non-cash gains, while continuing to advance its ophthalmology pipeline focused on Wnt pathway modulation.The Motley Fool · Aug 8, 2025

Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt SignalingSurrozen Publishes Study in eLife Demonstrating the Promise of the SWEETS Platform, a Unique TPD Technology, to Further Enhance Wnt SignalingGlobeNewswire Inc. · Jun 12, 2024

Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in MilanSurrozen Presents Preliminary Results from Phase 1a Study of SZN-043 at the 2024 European Association for the Study of the Liver (EASL) in MilanGlobeNewswire Inc. · Jun 10, 2024

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated HepatitisSurrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated HepatitisGlobeNewswire Inc. · Jun 4, 2024

Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual MeetingSurrozen Presents Data Demonstrating the Promise of Antibody Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at ARVO 2024GlobeNewswire Inc. · May 9, 2024

Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary FibrosisSurrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary FibrosisGlobeNewswire Inc. · Apr 3, 2024

Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq RulesSurrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq RulesGlobeNewswire Inc. · Apr 1, 2024

Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043GlobeNewswire Inc. · Apr 1, 2024

Surrozen Provides Corporate Update on Clinical ProgramsAnnounces strategic prioritization of clinical programs to focus on development of SZN-043 for Alcohol-Associated HepatitisGlobeNewswire Inc. · Jan 18, 2024

Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionGainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results. Capri Holdings Limited (NYSE: CPRI) climbed 56.1% to $54.03 after Tapestry announced a definitive agreement to acquire the company. Blend Labs, Inc. (NYSE: BLND) rose 32% to $1.6198 following better-than-expected second-quarter results. Athersys, Inc. (NASDAQ: ATHX) gained 31% to $0.5783. Yellow Corporation (NASDAQ: YELL) climbed 30% to $2.21. Holley Inc. (NYSE: HLLY) surged 26% to $7.83 after the company posted upbeat second-quarter results and raised FY23 revenue outlook. WeWork Inc. (NYSE: WE) shares gained 21% to $0.1560. WeWork shares fell over 38% on Wednesday after the company reported worse-than-expected second-quarter financial results. LifeMD, Inc. (NASDAQ: LFMD) climbed 20% to $4.39 following strong quarterly results. YETI Holdings, Inc. (NYSE: YETI) climbed 19% to $47.08 after the company reported better-than-expected second-quarter adjusted EPS results and raised FY23 adjusted EPS and sales growth guidance. AppLovin Corporation (NASDAQ: APP) shares gained 19% to $34.97 after the company reported better-than-expected second-quarter results. Alarm.com Holdings, Inc. (NASDAQ: ALRM) climbed 18.8% to $58.48 after the company reported better-than-expected second-quarter financial results and issued guidance. CleanSpark, Inc. (NASDAQ: CLSK) rose 17.5% to $5.94 following a narrower-than-expected quarterly loss. CS Disco, Inc. (NYSE: LAW) gained 16.3% to $9.93 following strong quarterly results. Carrols Restaurant Group, Inc. (NASDAQ: TAST) gained 16% to $7.18 following strong quarterly results. Seneca Foods Corporation (NASDAQ: SENEA) jumped 15.4% to $47.45 following quarterly results. PHAXIAM Therapeutics S.A. (NASDAQ: PHXM) shares climbed 15.1% to $0.5020 after gaining 6% on Wednesday. Entravision Communications Corporation (NYSE: EVC) rose 14.7% to $4.2550. MacroGenics, Inc. (NASDAQ: MGNX) surged 14.4% to $5.70 after posting a profit for the second quarter. GoodRx Holdings, Inc. (NASDAQ: GDRX) rose 14.4% to $9.09. Bruush Oral Care Inc. (NASDAQ: BRSH) gained 14% to $4.85. Missfresh Limited (NASDAQ: MF) climbed 12.9% to $1.75. LiveRamp Holdings, Inc. (NASDAQ: RAMP) gained ...Benzinga · Aug 10, 2023

SRZNSurrozen, Inc. Common

SRZN

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any SRZN yet.

Related Tickers

Earnings

Mkt Cap

$276.1M

Volume

232.39K

Next Earnings

November 6th